T2 Biosystems, Inc. Common Stock Delisted from Nasdaq

25-NSE/AListing RiskneutralImpact20

TTOO Price

Chart unavailable

N/A$0.00 (+0.00%)

Chart unavailable

Why It Matters

This Form 25 filing formally confirms the delisting of T2 Biosystems, Inc. common stock from Nasdaq, an event previously announced

Listing Status Amendment

Removed Security: Common Stock
Exchange / Venue: Nasdaq Stock Market LLCContinued trading: OTC Markets
Removal Basis: No longer qualified for listingRule 12d2-2(b)
Effective / Removal Date: July 21, 2025Trading suspended February 12, 2025

Summary

Add Stock Radar as a preferred source on GoogleAdd Stock Radar on Google

T2 Biosystems, Inc. common stock was formally removed from listing on the Nasdaq Stock Market LLC, effective July 21, 2025. Trading was suspended on February 12, 2025. This filing confirms the delisting action and its effective date, following prior announcements

AdvertisementResponsive display

Original Filing Text

SEC filing text preserved from the raw item store.

UNITED STATES

OMB APPROVAL

OMB Number:		3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:		1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-36571

Issuer:	T2 Biosystems, Inc.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	101 Hartwell Avenue
	Lexington	MASSACHUSETTS	02421
Telephone number:				781-457-1230

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-07-10	By	Aravind Menon		Hearings Advisor
Date		Name		Title

¹	Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.